In contrast to these diseases, upregulated IGF-1 expression or signaling is observed in many fibrotic lung diseases such as idiopathic pulmonary fibrosis, late-stage sarcoidosis, and secondary fibrosis (31, 36–40). Here, IGF1 is linked to lung disorder.